Laura Bartko, CNM in Beavercreek, OR - Advanced Practice Midwife

Laura Bartko, CNM is a Advanced Practice Midwife based in Beavercreek, Oregon. Laura Bartko is licensed to practice in Oregon (license number 200950003NP) and her current practice location is 23841 S Fellows Rd, Beavercreek, Oregon. She can be reached at her office (for appointments etc.) via phone at (503) 860-0082.

NPI number for Laura Bartko is 1033345038 and her current mailing address is 23841 S Fellows Rd, Beavercreek, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1033345038.

Contact Information

	Laura Bartko, CNM
	23841 S Fellows Rd, Beavercreek, OR 97004-9726
	(503) 860-0082
	Not Available

Provider's Profile

Full Name	Laura Bartko
Gender	Female
Speciality	Advanced Practice Midwife
Location	23841 S Fellows Rd, Beavercreek, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1033345038
Provider Enumeration Date: 06/03/2009
Last Update Date: 06/03/2009

Medical Identifiers

Medical identifiers for Laura Bartko such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033345038	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	200950003NP (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Laura Bartko is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Laura Bartko, CNM 23841 S Fellows Rd, Beavercreek, OR 97004-9726 Ph: (503) 860-0082	Laura Bartko, CNM 23841 S Fellows Rd, Beavercreek, OR 97004-9726 Ph: (503) 860-0082

News Archive

BMJ investigation raises concern on rosiglitazone diabetes drug safety

A BMJ investigation into the top-selling diabetes drug rosiglitazone (Avandia) raises concerns about its safety and the whole system by which drugs are evaluated, regulated, and promoted around the world.

Adherence to diabetes medication lowers risk of hospitalization

Individuals with diabetes who adhere to their medication had lower risk of hospitalization by one-third when compared to patients who do not adhere to their medication, according to a new study. The results of the study by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, are being presented the last week in April at the Academy of Managed Care Pharmacy's 23rd Annual Meeting and Showcase in Minneapolis, Minn.

NYU Langone completes study designs for NIH research initiative on long-term impact of COVID-19

NYU Langone Health, as the Clinical Science Core for the National Institutes of Health's RECOVER initiative, has, since the announcement of the beginning of its operations on June 10, convened more than 100 researchers from 35 institutions as well as patients to finalize the main study protocols for the adult, pediatric, and autopsy patient groups (cohorts).

Resistant gut bacteria will not go away by themselves

E. coli bacteria that have developed resistance to antibiotics will probably still be around even if we stop using antibiotics, as these strains have the same good chance as other bacteria of continuing to colonise the gut, according to a thesis at the Sahlgrenska Academy.

Experts raise questions about routine use of surrogate endpoints for drug approvals

A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.

Laura Bartko, CNM - Advanced Practice Midwife in Beavercreek, OR